Table 2. | Description of studies included in the review |
| Study |
Year of publication |
Study |
Follow-up (months) |
Method |
Patients (n) |
Implants (n) |
Implant system | Implant length/diameter (mm) | Insertion torque value (Ncm) |
|---|---|---|---|---|---|---|---|---|---|
| Feng et al. [35] | 2023 | Prospective study | 3 | CBCT | 22 | 65 |
Straumann® Bone Level Implant System (Straumann AG; Basel, Switzerland) |
NR |
31.44 (SD 6.54) |
| de Elío Oliveros [36] | 2020 | Observational clinical study | Direct | CBCT | 48 | 160 | BEGO Implant (GmbH & Co. KG; Bremen, Germany) | NR | ≤ 30 to > 50 |
| Daher et al. [37] | 2021 | Randomized controlled trial | 3 to 3.5, 12 | OPG, CBCT | 18 | 120 | NobelActive® (Nobel Biocare AB; Gothenburg, Sweden) |
Length: 10, 11.5, 13, 15. Diameter: 3.5, 4.3 |
< 10 to > 70 |
| Ivanova et al. [38] | 2021 | Clinical study | 4 | CBCT | 90 | 90 | AB Dental Implants (AB Dental Devices Ltd; Ashdod, Israel) |
Length: ≤ 6.0, (> 6 to < 10) or ≥ 10. Diameter: ≤ 3.0 to < 3.75, ≥ 3.75 to < 5 or ≥ 5 |
NR |
| Vallecillo et al. [39] | 2021 | Prospective cross-sectional study | 2, 3 | RFA | 31 | 60 | Zimmer TSV (Zimmer Biomet Dental; Palm Beach Gardens, Florida, USA) |
Length: 10.
Diameter: 3.7 or 4.1 |
40 |
| Cassetta et al. [40] | 2022 | Prospective cross-sectional study | 2, 6, 12 |
Osstell™ device (Osstell AB; Gothenburg, Sweden) |
142 | 268 | DIO Implant (DIO Corporation; Busan, South Korea) |
Length: 10, 12 or 14.
Diameter: 3.8, 4.1, 4.5, 5.0 or 5.3 |
> 50 |
N = number; NR = not reported; CBCT = cone-beam computed tomography; OPG = orthopantomogram; RFA = resonance frequency analysis. |
.png)
.png)